Influence of protein corona and caveolae-mediated endocytosis on nanoparticle uptake and transcytosis
The DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index.
Abstract
Transcytosis of nanoparticles (NPs) is emerging as an attractive alternative to the paracellular route in cancer drug delivery with studies suggesting targeting caveolae-mediated endocytosis to maximize NP transcytosis. However, there are limited studies on transcytosis of NPs, especially for corona-coated NPs. Most studies focused on cellular uptake as an indirect measure of the NP's transcellular permeability (Pd). Here, we probed the effect of protein corona on the uptake and transcytosis of 20, 40, 100, and 200 nm polystyrene nanoparticles (pNP-PC) across HUVECs in a microfluidic channel that modelled the microvasculature. We observed increased cell uptake with size of pNP-PC although it was the smallest 20 nm pNP-PC that exhibited the highest transcellular Pd. In the absence of corona however, cell uptake decreased with size, and the largest 200 nm pNP-PEG exhibited the lowest transcellular Pd. By inhibiting caveolae-mediated endocytosis in HUVECs, smaller pNPs had a larger drop in cell uptake than larger pNPs, regardless of surface coating. However, only the smallest (20 nm) and largest (200 nm) pNP-PC had a decrease in Pd following inhibition with MβCD. Our findings showed that the protein corona affected the transcytosis of NPs, and their uptake by caveolae-mediated endocytosis did not necessarily lead to transcytosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527
Analysis of nanoparticle delivery to tumours
Wilhelm, S., Tavares, A. J., Dai, Q., Ohta, S., Audet, J., Dvorak, H. F., & Chan, W. C. W. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.14 · Cited by 5,218
Regulated portals of entry into the cell
Conner, S. D., & Schmid, S. L. (2003) · Nature · doi:10.1038/nature01451 · Cited by 3,805
Doherty, G. J., & McMahon, H. T. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.78.081307.110540 · Cited by 3,075
Biomolecular coronas provide the biological identity of nanosized materials
Monopoli, M. P., Åberg, C., Salvati, A., & Dawson, K. A. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.207 · Cited by 3,017
Lundqvist, M., Stigler, J., Elia, G., Lynch, I., Cedervall, T., & Dawson, K. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805135105 · Cited by 2,823
Maeda, H. (2001) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(00)00013-3 · Cited by 2,495
Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology
Tenzer, S., Docter, D., Kuharev, J., Musyanovych, A., Fetz, V., Hecht, R., Schlenk, F., Fischer, D., Kiouptsi, K., Reinhardt, C., et al. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2013.181 · Cited by 2,283
Nanoparticle PEGylation for Imaging and Therapy
Jokerst, J. V., Lobovkina, T., Zare, R. N., & Gambhir, S. S. (2011) · Nanomedicine · doi:10.2217/nnm.11.19 · Cited by 2,046
Exploiting the enhanced permeability and retention effect for tumor targeting
Iyer, A. K., Khaled, G., Fang, J., & Maeda, H. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.07.005 · Cited by 1,846
Research works printed but not linked: 9
- Wang, 2014, Austin J. Anal. Pharm. Chem., 1, 1018
- Wang, 2011, IUBMB Life, 63, 659, 10.1002/iub.485 · DOI · Paper page
- Oh, 2014, Int. J. Nanomed., 9, 51
- Cheng, 2015, ACS Appl. Mater. Interfaces, 7, 20568, 10.1021/acsami.5b04290 · DOI · Paper page
- Vercauteren, 2010, Mol. Ther., 18, 561, 10.1038/mt.2009.281 · DOI · Paper page
- Zhang, 2012, FASEB J., 26, 641.623
- Kiss, 2009, J. Cell. Mol. Med., 13, 1228, 10.1111/j.1582-4934.2009.00754.x · DOI · Paper page
- Porro, 1995, Cancer Immunol. Immunother., 40, 213
- Jain, 1987, Cancer Res., 47, 3039
Cited by
The entry of nanoparticles into solid tumours
Sindhwani, S., Syed, A. M., Ngai, J., Kingston, B. R., Maiorino, L., Rothschild, J., MacMillan, P., Zhang, Y., Rajesh, N. U., Hoang, T., et al. (2020) · Nature Materials · doi:10.1038/s41563-019-0566-2 · Cited by 1,732
Understanding nanoparticle endocytosis to improve targeting strategies in nanomedicine
Sousa de Almeida, M., Susnik, E., Drasler, B., Taladriz-Blanco, P., Petri-Fink, A., & Rothen-Rutishauser, B. (2021) · Chemical Society Reviews · doi:10.1039/d0cs01127d · Cited by 1,079
Kianfar, E. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00896-3 · Cited by 471
Microfluidic Devices: A Tool for Nanoparticle Synthesis and Performance Evaluation
Gimondi, S., Ferreira, H., Reis, R. L., & Neves, N. M. (2023) · ACS Nano · doi:10.1021/acsnano.3c01117 · Cited by 376
The challenges of oral drug delivery via nanocarriers
Reinholz, J., Landfester, K., & Mailänder, V. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1501119 · Cited by 233
“To our knowledge, the only study so far that focused on the utilization of a protein corona for transcytosis reported differences in transcytosis efficiencies after the formation of a protein corona in HUVECs; however, these effects varied widely between different sized NPs (Ho et al., 2018).”
BackgroundTargeting immune cells for cancer therapy
Gun, S. Y., Lee, S. W. L., Sieow, J. L., & Wong, S. C. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101174 · Cited by 229
Liu, J., Cabral, H., & Mi, P. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115239 · Cited by 229
Brown, T. D., Habibi, N., Wu, D., Lahann, J., & Mitragotri, S. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.0c00743 · Cited by 182
Polymeric Micellar Systems—A Special Emphasis on “Smart” Drug Delivery
Negut, I., & Bita, B. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15030976 · Cited by 184
“The EPR effect of micelles could be used to regulate the hydrophobic agent release in tumor tissue.”
BackgroundInfluentialNanocarrier‐Mediated Cytosolic Delivery of Biopharmaceuticals
He, W., Xing, X., Wang, X., Wu, D., Wu, W., Guo, J., & Mitragotri, S. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201910566 · Cited by 176
The interaction between nanoparticles-protein corona complex and cells and its toxic effect on cells
Liu, N., Tang, M., & Ding, J. (2020) · Chemosphere · doi:10.1016/j.chemosphere.2019.125624 · Cited by 169
Solid lipid nanoparticles for enhanced oral absorption: A review
Salah, E., Abouelfetouh, M. M., Pan, Y., Chen, D., & Xie, S. (2020) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2020.111305 · Cited by 152
CARBON DOTS: Bioimaging and Anticancer Drug Delivery
Bartkowski, M., Zhou, Y., Mustafa, M. N. A., Eustace, A. J., & Giordani, S. (2024) · Chemistry - A European Journal · doi:10.1002/chem.202303982 · Cited by 156
Polydopamine Coating Enhances Mucopenetration and Cell Uptake of Nanoparticles
Poinard, B., Kamaluddin, S., Tan, A. Q. Q., Neoh, K. G., & Kah, J. C. Y. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b18107 · Cited by 126
Self-citationMills, J. A., Liu, F., Jarrett, T. R., Fletcher, N. L., & Thurecht, K. J. (2022) · Biomaterials Science · doi:10.1039/d2bm00181k · Cited by 138
Singh, N., Marets, C., Boudon, J., Millot, N., Saviot, L., & Maurizi, L. (2021) · Nanoscale Advances · doi:10.1039/d0na00863j · Cited by 116
Nucleic acid drug vectors for diagnosis and treatment of brain diseases
Lu, Z.-G., Shen, J., Yang, J., Wang, J.-W., Zhao, R.-C., Zhang, T.-L., Guo, J., & Zhang, X. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01298-z · Cited by 106
Application of advances in endocytosis and membrane trafficking to drug delivery
Ju, Y., Guo, H., Edman, M. C., & Hamm‐Alvarez, S. F. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.026 · Cited by 116
Strategies for Delivering Nanoparticles across Tumor Blood Vessels
Sheth, V. M., Wang, L., Bhattacharya, R., Mukherjee, P., & Wilhelm, S. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202007363 · Cited by 109
Nanoparticle entry into cells; the cell biology weak link
Griffiths, G. W., Grüenberg, J., Marsh, M., Wohlmann, J., Jones, A. T., & Parton, R. G. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114403 · Cited by 104
Unexpected Size Effect: The Interplay between Different‐Sized Nanoparticles in Their Cellular Uptake
Li, L., Xi, W., Su, Q., Li, Y., Yan, G., Liu, Y., Wang, H., & Cao, A. (2019) · Small · doi:10.1002/smll.201901687 · Cited by 102
Engineering Tumor-Targeting Nanoparticles as Vehicles for Precision Nanomedicine
Gonda, A., Zhao, N., Shah, J. V., Calvelli, H. R., Kantamneni, H., Francis, N. L., & Ganapathy, V. (2019) · Med One · doi:10.20900/mo.20190021 · Cited by 109
“NP size [34] and surface modifications with ligands for vascular and/or tumor expressing receptors [35,36] have both been investigated with promising effects on transcytosis initiation and increased nanoparticle internalization.”
BackgroundHo, Y. T., Azman, N. ‘., Loh, F. W. Y., Ong, G. K. T., Engudar, G., Kriz, S. A., & Kah, J. C. Y. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00743 · Cited by 76
Self-citationÇiftçi, F., Özarslan, A. C., Kantarci, İ. C., Yelkenci, A., Tavukçuoğlu, Ö., & Ghorbanpour, M. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17010121 · Cited by 103
“These processes, including endocytosis, clathrin-mediated endocytosis [135–137], caveolae-mediated endocytosis [138–140], and micropinocytosis [141–143], play a pivotal role in determining the efficiency and specificity of nanoparticle-mediated drug delivery.”
Surface charge influences protein corona, cell uptake and biological effects of carbon dots
Arezki, Y., Delalande, F., Schaeffer‐Reiss, C., Cianférani, S., Rapp, M., Lebeau, L., Pons, F., & Ronzani, C. (2022) · Nanoscale · doi:10.1039/d2nr03611h · Cited by 79
In Situ Analysis of Weakly Bound Proteins Reveals Molecular Basis of Soft Corona Formation
Sánchez-Guzmán, D., Giraudon--Colas, G., Marichal, L., Boulard, Y., Wien, F., Degrouard, J., Baeza‐Squiban, A., Pin, S., Renault, J., & Devineau, S. (2020) · ACS Nano · doi:10.1021/acsnano.0c04165 · Cited by 70
Physics in nanomedicine: Phenomena governing the in vivo performance of nanoparticles
Lane, L. A. (2020) · Applied Physics Reviews · doi:10.1063/1.5052455 · Cited by 62
Low nanogel stiffness favors nanogel transcytosis across an in vitro blood–brain barrier
Ribovski, L., de Jong, E., Mergel, O., Zu, G., Keskin, D., van Rijn, P., & Zuhorn, I. S. (2021) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2021.102377 · Cited by 68
Iron Oxide Nanoparticle Coatings Dictate Cell Outcomes Despite the Influence of Protein Coronas
Portilla, Y., Mellid, S., Paradela, A., Ramos-Fernández, A., Daviu, N., Sanz-Ortega, L., Pérez-Yagüe, S., Morales, M. P., & Barber, D. F. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c20066 · Cited by 59
Research Progress on the Mechanism of Nanoparticles Crossing the Intestinal Epithelial Cell Membrane
He, Y., Cheng, M., Yang, R., Li, H., Lu, Z., Jin, Y., Feng, J., & Tu, L. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15071816 · Cited by 63
“Caveolae-mediated endocytosis (CavME) is another important pathway for receptorspecific nanoparticle internalization [60].”
BackgroundProtein corona, influence on drug delivery system and its improvement strategy: A review
Guo, F., Luo, S., Wang, L., Wang, M., Wu, F., Wang, Y., Jiao, Y., Du, Y., Yang, Q., Yang, X., et al. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.128513 · Cited by 75
Insights into Characterization Methods and Biomedical Applications of Nanoparticle–Protein Corona
Li, Y., & Lee, J. (2020) · Materials · doi:10.3390/ma13143093 · Cited by 61
“Furthermore, significant increases in the uptake of 100 and 200 nm polystyrene NPs by human umbilical vein endothelial cells (HUVECs) have been observed in the presence of an FBS corona; however, almost no changes have been observed in the cellular uptake of FBS-coated polystyrene NPs (20 and 40 nm in diameter) [126].”
BackgroundWen, J., Sun, H., Liu, Z., Zhu, X., Qin, Z., Song, E., & Song, Y. (2022) · Environmental Science & Technology Letters · doi:10.1021/acs.estlett.2c00650 · Cited by 56
Youden, B., Jiang, R., Carrier, A. J., Servos, M. R., & Zhang, X. (2022) · ACS Nano · doi:10.1021/acsnano.2c06337 · Cited by 56
Recent Advances in The Analysis of Nanoparticle-Protein Coronas
Ovais, M., Nethi, S. K., Ullah, S., Ahmad, I., Mukherjee, S., & Chen, C. (2020) · Nanomedicine · doi:10.2217/nnm-2019-0381 · Cited by 40
Khanal, D., Lei, Q., Pinget, G. V., Cheong, D. A., Gautam, A. S., Yusoff, R., Su, B., Yamaguchi, S., Kondyurin, A. V., Knowles, J. C., et al. (2020) · Nanoscale Advances · doi:10.1039/d0na00231c · Cited by 44
Zhu, Y. F., Jiang, P., Luo, B., Lan, F., He, J. H., & Wu, Y. (2019) · Nanoscale · doi:10.1039/c8nr08614a · Cited by 41
Li, H., Bai, L., Liang, S., Chen, X., Gu, X., Wang, C., & Gu, C. Z. (2025) · Eco-Environment & Health · doi:10.1016/j.eehl.2025.100138 · Cited by 44
Fan, W., Xiang, J., Wei, Q., Tang, Y., Piao, Y., Shao, S., Zhou, Z., Tang, J., Li, Z., & Shen, Y. (2023) · Nano Letters · doi:10.1021/acs.nanolett.3c00449 · Cited by 36
Ye, J.-Y., Chen, Z., Huang, C., Huang, B., Zheng, Y.-R., Zhang, Y., Lu, B., He, L., Liu, C., & Long, X. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s259993 · Cited by 36
Chen, X., Luo, X., Yin, W., Cui, W., He, Y., Tian, T., & Lin, Y. (2025) · ACS Nano · doi:10.1021/acsnano.5c03945 · Cited by 40
Zhang, Y., Zhang, Y., Wu, J., Liu, J., Kang, Y., Hu, C., Feng, X., Liu, W., Luo, H., Chen, A., et al. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.10.067 · Cited by 31
Martín-Pérez, J., Villacorta, A., Banaei, G., Morataya-Reyes, M., Tavakolpournegari, A., Marcos, R., Hernández, A., & García‐Rodríguez, A. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.173236 · Cited by 35
Mutalik, S. P., Pandey, A. P., & Mutalik, S. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.02.150 · Cited by 27
Liu, L., Xu, Y., Ma, Y., Duan, F., Wang, C., Feng, J., Yin, H., Sun, L., Li, P., & Li, Z. (2025) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2025.137596 · Cited by 29
Wang, Z., Zhang, C., Liu, X., Huang, F., Wang, Z., & Yan, B. (2020) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2020.110884 · Cited by 27
Merino, J. J., & Cabaña-Muñoz, M. E. (2023) · Micromachines · doi:10.3390/mi14112068 · Cited by 25
Cell and biomaterial delivery strategies to induce immune tolerance
Scotland, B. L., Shaw, J. R., Dharmaraj, S., Caprio, N., Cottingham, A. L., Lasola, J. J., Sung, J. J., & Pearson, R. M. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115141 · Cited by 27
Uncovering layer by layer the risk of nanoplastics to the environment and human health
Antunes, J., Sobral, P., Branco, V., & Martins, M. (2024) · Journal of Toxicology and Environmental Health Part B · doi:10.1080/10937404.2024.2424156 · Cited by 21
PepH3-modified nanocarriers for delivery of therapeutics across the blood-brain barrier
Szecskó, A., Mészáros, M., Simões, B. T., Cavaco, M. C., Chaparro, C. I. P., Porkoláb, G., Castanho, M. A. R. B., Deli, M. A., Neves, V., & Veszelka, S. (2025) · Fluids and Barriers of the CNS · doi:10.1186/s12987-025-00641-0 · Cited by 30
“The rapidly formed protein corona on the NPs may define a biological response and influence the cellular uptake and penetration of NPs across the BBB [49–52].”
Interactions of nanoparticles with living and synthetic bio-membranes
Kariuki, R., Mirihana, K. A., Penman, R., Hung, A., Meftahi, N., Bryant, G., Ramsland, P. A., Voïtchovsky, K., Conn, C. E., Contini, C., et al. (2025) · Chemical Society Reviews · doi:10.1039/d5cs00841g · Cited by 26
Han, H., Cho, J., Seong, E., Park, E.-J., Lee, G., Kim, D., Yang, Y., Oh, J.-H., Yoon, S., Lee, T. G., et al. (2020) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.114890 · Cited by 21
Liu, C., Zhao, W., Zhang, L., et al. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14102157 · Cited by 21
“Research has demonstrated that interactions between RGD ligand and integrin receptors [20–22,48] or protein crona [49] coated on lipoplexes can trigger transcytosis.”
BackgroundCoating of magnetic nanoparticles affects their interactions with model cell membranes
Lazaratos, M., Karathanou, K., Mainas, E., Chatzigoulas, A., Pippa, Ν., Demetzos, C., & Cournia, Z. (2020) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2020.129671 · Cited by 21
Geppert, M., Sigg, L., & Schirmer, K. (2021) · Environmental Science Nano · doi:10.1039/d1en00050k · Cited by 20
Maravajjala, K. S., Swetha, K. L., Sharma, S., Padhye, T., & Roy, A. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.102041 · Cited by 21
Wang, X., Zhao, W., Fan, J.-Z., Jia, L.-C., Lu, Y., Zeng, L., Lv, Y., & Sun, X. (2022) · Molecules · doi:10.3390/molecules27082419 · Cited by 21
“Designing NPs to favor caveolae-mediated endocytosis potentially enhances transcytosis [33,34].”
BackgroundChiral nanomaterials in tissue engineering
Yang, Z., Jaiswal, A. K., Yin, Q., Lin, X., Liu, L., Li, J., Liu, X., Xu, Z., Li, J. J., & Yong, K. (2024) · Nanoscale · doi:10.1039/d3nr05003c · Cited by 20
Geng, Y., Wang, J., Wang, X., Liu, J., Zhang, Y., Niu, W., Basit, A., Liu, W., & Jiang, W. Z. (2019) · Nanomedicine · doi:10.2217/nnm-2018-0296 · Cited by 18
Kandasamy, G., Manisekaran, R., & Arthikala, M. (2023) · Environmental Research · doi:10.1016/j.envres.2023.117447 · Cited by 17
Combined Toxicity of Metal Nanoparticles: Comparison of Individual and Mixture Particles Effect
Engin, A. B. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-49844-3_7 · Cited by 19
Wang, J., Chen, M., Li, S., & Ye, R. D. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00188 · Cited by 15
Endocytosis-mediated redistribution of antibiotics targets intracellular bacteria
Qu, S., & Zhu, K. (2023) · Nanoscale · doi:10.1039/d2nr05421c · Cited by 14
Li, Y., Niu, X., Li, L., Zhang, X., Yang, K., & Yue, T. (2021) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2021.115990 · Cited by 13
Poly(2-Propylacrylic Acid) Increases In Vitro Bioactivity of Chitosan/mRNA Nanoparticles
Jeandupeux, E., Alameh, M., Ghattas, M., Crescenzo, G. D., & Lavertu, M. (2021) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2021.06.003 · Cited by 13
Neupane, R., Malla, S., Karthikeyan, C., Asbhy, C. R., Boddu, S. H. S., Babu, R. J., & Tiwari, A. K. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125356 · Cited by 18
Wang, Y., Feng, J., & Lin, Y. (2021) · Nanotechnology · doi:10.1088/1361-6528/ac44e8 · Cited by 12
“…studies have shown that 200 nm polystyrene nanoparticles exhibit the best cell uptake as compared to other smaller sizes of nano-particles, including 10 nm, 50 nm, and 100 nm particles [ 28 ] as well as better in vitro BBB penetration than the nano-particles with a diameter of 500 nm do [ 30 ] .”
Liu, R., Yu, D., El‐Aty, A. M. A., & Tan, M. (2023) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2023.104179 · Cited by 11
Matthew, S. A. L., & Seib, F. P. (2024) · Advanced Therapeutics · doi:10.1002/adtp.202400130 · Cited by 11
Tailoring the Properties of Functional Materials With N ‐Oxides
Friedrich, T., Kobus, M., Mesgarha, S., Moretto, E., Grosche, L., & Maison, W. (2025) · Advanced Functional Materials · doi:10.1002/adfm.202515786 · Cited by 11
Vercellino, S., Kokalari, I., Cantoral, M. L., Petseva, V., Cursi, L., Casoli, F., Castagnola, V., Boselli, L., & Fenoglio, I. (2022) · Biomaterials Science · doi:10.1039/d2bm00220e · Cited by 9
Lu, W., Tian, H., Qian, P., Li, Y., Wang, Y., Ge, Y., Sai, W., Gao, X., & Yao, W. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15069 · Cited by 7
Kannan, R., Datta, A., Prabakaran, P., et al. (2021) · Chemical Communications · doi:10.1039/d1cc05652b · Cited by 8
Cell-specific mRNA delivery via nanobody-functionalized lipid nanoparticles
Chen, L., der Weken, H. V., Zwaenepoel, O., Okkelman, I. A., Aelvoet, J., Denberghe, E. V., Gettemans, J., Dmitriev, R. I., Geest, B. G. D., Cox, E., et al. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114365 · Cited by 13
Suresh, P. K., Banerjee, A., & Singh, P. (2023) · OpenNano · doi:10.1016/j.onano.2023.100134 · Cited by 8
Cui, G., Li, J., Li, J., Wang, H., & Tan, M. (2023) · Food Frontiers · doi:10.1002/fft2.305 · Cited by 7
Peptide-based assembled nanostructures that can direct cellular responses
Huang, H., & Kiick, K. L. (2022) · Biomedical Materials · doi:10.1088/1748-605x/ac92b5 · Cited by 9
“Studies have also shown that NPs sized less than 200 nm [78, 187, 188] will more easily be trafficked through clathrin- and caveolin-mediated endocytosis pathways, with caveolin-mediated pathways pre-”
Lesani, P., Zare, I., Khetarpaul, M., Lu, Z., Ghaee, A., & Zreiqat, H. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115742 · Cited by 7
Patel, S., Salaman, S. D., Kapoor, D. U., Yadav, R., & Sharma, S. K. (2024) · Zeitschrift für Naturforschung C · doi:10.1515/znc-2024-0208 · Cited by 10
Molecular Entrapment in Thermophilic Ferritin for Nanoformulation in Photodynamic Therapy
Pasula, R. R., Kuniyil, A., & Lim, S. (2020) · Advanced Therapeutics · doi:10.1002/adtp.201900172 · Cited by 7
Fundamentals behind the success of nanotechnology in cancer treatment and diagnosis
Chowdhury, M. M. H., Kubra, K., & Islam, A. (2024) · OpenNano · doi:10.1016/j.onano.2024.100215 · Cited by 6
Navigating the Endothelial Barrier: A Multiscale Framework for Precision Nanomedicine
Ma, H., Yang, L., Deng, C., Zhao, J., Tian, F., Zhang, X., Yu, G., Yan, B., & Yue, T. (2026) · Small · doi:10.1002/smll.202511618 · Cited by 8
Nanomaterial Endocytosis: Quantification of Adsorption and Ingestion Mechanisms
Sannidhi, A., Zhou, C., Choi, Y., David, A. E., Todd, P. W., & Hanley, T. R. (2023) · Magnetochemistry · doi:10.3390/magnetochemistry9020037 · Cited by 5
Investigation of nanoparticle extravasation pathways in tumor vessel-on-a-chip devices
Dávila, S., Martín–Asensio, A., Diego, E. S., Hernández, J. J., & Rodríguez, I. (2025) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2025.102863 · Cited by 5
Applications of Carbon Dots and Graphene Quantum Dots in Treatment of Diabetes
Nakayama, S., Shepard, E. J., Banerjee, A., Yang, X., & Crans, D. C. (2026) · Molecules · doi:10.3390/molecules31060941 · Cited by 6
“Drug loading on these carbon nanocarriers via adsorption, covalent conjugation, or polymer coatings modulates protein corona formation and receptor engagement, thereby biasing the balance between specific receptor-mediated pathways and non-specific pinocy-tosis [168].”
Tiwary, P., Oswal, K., Varghese, R., & Gupta, P. K. (2026) · Journal of Nanotheranostics · doi:10.3390/jnt7020011 · Cited by 4
“Despite this size variability, it is expected that the vesicle size differences may drive the uptake mechanism [30,32].”
Hosokawa, M., Inaba, M., Tanaka, M., & Ogawara, K. (2023) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2023.10.018 · Cited by 3
Nanoparticle-mediated cardiotoxicity and nanomedicine interventions in cancer treatment
Oisakede, E. O., Oyedeji, O. O., Olawuyi, O. F., Alabi, J. O., Daniel, R. I. A., & Olawade, D. B. (2026) · Nano TransMed · doi:10.1016/j.ntm.2026.100113 · Cited by 4
Protein and peptide nanoparticles for drug delivery applications
Nair, M. P., Chandra, A., Krishnan, A., Chandra, A., Basha, R. R., Orimoloye, H. T., Raut, S., Gayathri, V., Mudgapalli, V. V., & Vishwanatha, J. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-90838-2.00011-4 · Cited by 4
Wei, X., Liu, Q., Wang, Z., & Xu, G. (2024) · Journal of Nanoparticle Research · doi:10.1007/s11051-024-06079-z · Cited by 3
“In the transcellular process, nanoparticles were endocytosed from the apical side and then transported across the cells [28].”
Lin, C., Teng, C., Li, B., & He, W. (2024) · Chinese Chemical Letters · doi:10.1016/j.cclet.2024.110450 · Cited by 3
Tat, S. S., Datkhile, K. D., Pawar, J., Mohite, A. R., & Sharma, T. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27135837 · Cited by 2
“High-flavonoid coro-nas activate caveolae-mediated pathways that lead to transcytosis and inhibit lysosomal degradation [82].”
Bionanomateriais para o cruzamento de barreira biológica e entrega controlada
Ribovski, L. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.76.2020.tde-29092020-101056
Exploring protein based nanoparticles for drug delivery: materials, methods and applications
Sahihi, M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-44593-4.00009-2
Abubakari, A. W., M-Kamal, H. S., Ahmad, A., Isiaka, I. D., & Johnson, A. M. (2026) · Journal of Nanoparticle Research · doi:10.1007/s11051-026-06552-x · Cited by 1
“In contrast, caveolae-mediated endocytosis (CavME) involves small, flask-shaped membrane invaginations and offers a significant advantage for drug delivery, as materials internalized this way can bypass lysosomal degradation and be shuttled through the cell via transcytosis [31, 72–75].”
Giraudon--Colas, G. (2021) · theses.fr (ABES) · doi:10.70675/0817816ezfc2az4910z858az0afd2a00cfad
Fasquelle, F. (2020) · theses.fr (ABES) · doi:10.70675/07ac95f5zf304z49f0z8be8za5ad05bc60da
Elaboration de nanoparticules inorganiques pour l’étude des interactions nanoparticules-protéines
Marets, C. (2023) · theses.fr (ABES) · doi:10.70675/134c9238ze110z4d2bz8c37z3b3f3fa1fc18
Kumwan, B., Meachasompop, P., Adisornprasert, Y., et al. (2026) · Aquaculture Reports · doi:10.1016/j.aqrep.2026.103784
Nanotechnology‐Enabled Targeted Protein Degradation: Strategies, Opportunities, and Challenges
Zhu, H., Zhang, Y., Ning, Y., Yang, C. J., Zhang, G., & Zhu, Z. (2026) · Small Methods · doi:10.1002/smtd.70928 · Cited by 1
Metadata
- Authors
- Ho, Y. T., Kamm, R. D., & Kah, J. C. Y.
- Affiliations
- National University of Singapore (SG)
- Singapore-MIT Alliance for Research and Technology (SG)
- Corresponding author
- Kamm, Roger D.
- Kah, James Chen Yong
- Venue
- Nanoscale
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2018
- Volume
- 10
- Issue
- 26
- Pages
- 12386-12397
- ISSN
- 2040-3364 (ISSN-L)
- 2040-3372
- OpenAlex
- W2808633174
- Cited by
- 102
- References
- 117
- Citations by year
- 2026: 10 · 2025: 12 · 2024: 11 · 2023: 16 · 2022: 9 · 2021: 12 · 2020: 22 · 2019: 8 · 2018: 2
- FWCI
- 3.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nanoscale (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministry of Education - Singapore
- Singapore-MIT Alliance for Research and Technology Centre
- National University of Singapore
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Caveolin-1 and cellular processes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Keywords
- protein corona, caveolae-mediated endocytosis, nanoparticle uptake, polystyrene nanoparticles, polyethylene glycol coating, endothelial cells, transcellular permeability, nanoparticle size, anticancer drug delivery
- MeSH terms
- Protein Corona, Endocytosis, Humans, Polystyrenes, Caveolae, Nanoparticles, Lab-On-A-Chip Devices, Transcytosis, Human Umbilical Vein Endothelial Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.